FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceuticals and concerns a therapeutic agent for improvement of skin properties containing a compound of formula 
(I): as an active ingredient.
EFFECT: invention provides a medical product effective for prevented dry skin, reduced skin roughness and skin darkening associated with hyperkeratosis ensured by skin moisture preservation, and effective for impaired skin functions for the various reasons.
3 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION OF DERMAL MEDICATION FOR EXTERNAL APPLICATION | 2010 |
|
RU2572694C2 |
| TREATMENT OF CHOLESTATIC ITCHING | 2018 |
|
RU2781281C2 |
| THERAPEUTIC OR PROPHYLACTIC AGENT FOR TREATING OR PREVENTING CACHEXIA | 2020 |
|
RU2825649C1 |
| THERAPEUTICAL OR PREVENTIVE MEANS FOR DISEASES OF BILIARY TRACTS | 2011 |
|
RU2554857C2 |
| THERAPEUTIC AGENT FOR TREATING RHINITIS | 2010 |
|
RU2502519C2 |
| DRUG FOR PREVENTION OR TREATMENT OF BRAIN ATROPHY | 2018 |
|
RU2759727C2 |
| TOPICAL AGENT FOR ACNE | 2014 |
|
RU2560698C1 |
| TRANSDERMAL GRANISETRON | 2004 |
|
RU2355387C2 |
| THERAPEUTIC AGENT FOR BILIARY TRACT CANCER TREATMENT | 2016 |
|
RU2728932C2 |
| DRUG FOR PREVENTION OR TREATMENT OF TAUPATHY | 2018 |
|
RU2739199C1 |
